Search results for: 'data in payer'

The increasing burden of neuropsychiatric conditions on healthcare systems and pharmacotherapy challenges including side effects, limited and delayed efficacy, and non-responsiveness calls for alternative solutions that are effective and easy to use. Neuromodulation devices use electrical or magnetic impulses to stimulate nerve activity. They can b...

The global enterprise medical imaging workflow orchestration solutions industry is undergoing rapid changes because of new technological developments, new clinical and administrative needs, and the introduction of new policies and regulations, making it necessary for industry participants to innovate to maintain a competitive edge. The healthca...

25 Mar 2022  |  North America  |  Frost Radar

Frost Radar™: North American Clinical Documentation Improvement Market, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facilita...

01 Oct 2019  |  Global  |  Market Research

Global Blockchain Technology Market in the Healthcare Industry, 2018–2022

Healthcare Industry Assesses Blockchain Potential to Optimize Healthcare Workflows and Improve Outcome-based Care Delivery Models

Infographics

×

Key Issues Addressed Key Benefits

As the healthcare market struggles to find a trade-off between the risk and reward of going digital, the potential application of Blockchain technology provides a timely solution to mitigate some of its pressing needs around trust and security with digital workflows. A Blockchain (or DLT) is a new data structure that creates trusted, distributed di...

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

The medical devices industry is facing significant challenges in the form of pricing pressures and a slow growth environment in the traditional markets. Among the traditional markets, the consumables and services segment is gaining traction from activities tied to the installation of new capital equipment, the gradual replacement of capital equipme...

The medical device industry faces significant pricing pressures as the consumables and services segment gains traction from activities tied to installing new equipment and replacing or refurbishing capital equipment. Medical device vendors are focused on new business models to provide multi-vendor services, online parts ordering, remote servicing, ...

03 Apr 2018  |  Asia Pacific  |  Market Outlook

Asia-Pacific Healthcare Outlook, 2018

The Year of Digital Innovation in Asia-Pacific

Infographics

×

The healthcare industry in Asia-Pacific (APAC) is expected to grow at 12.5% in 2018, making it one of the fastest growing regions in the world, as the global healthcare economy averages an annual growth rate of 4.8%. This positive growth is fuelled by increasing adoption of technology, innovative healthcare access programs, and delivery of care out...

Frost & Sullivan announces exciting new research from its Transformational Health program touching on some of the most important issues in healthcare now and in the future. This Frost & Sullivan research service presents a comprehensive analysis of the market potential and dynamics of the population health management (PHM) market in the United S...